Marker Therapeutics (MRKR) Return on Sales [ROS] (2017 - 2025)
Marker Therapeutics (MRKR) reported Return on Sales [ROS] of -170.74% for Q4 2025, up 0.75 percentage points from -171.48% a year earlier and up 2.57 percentage points from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Return on Sales [ROS] (2017 - 2025) Analysis & Trends
For FY2025, Marker Therapeutics posted Return on Sales [ROS] of -363.45%, down 194.76 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +5413.71 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -168.69% in FY2024 (+271.69 pp), -440.37% in FY2023 (+122.90 pp), -563.28% in FY2022 (+2616.05 pp) and -3179.32% in FY2021 (+2597.84 pp).
- The Q4 2025 figure ranks as the highest quarterly Return on Sales [ROS] since Q3 2024.
- Year over year, Return on Sales [ROS] gained in four of the last eight quarters, with an average year-over-year change of -25.68 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q3 2024 (a gain of 1117.62 percentage points); the low point was Q1 2025 (a drop of 1215.25 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -173.30% (Q3 2025), -594.79% (Q2 2025) and -1420.14% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Marker Therapeutics | 17.53 Mn | -42.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -170.74% |
| Sep 30, 2025 | -173.30% |
| Jun 30, 2025 | -594.79% |
| Mar 31, 2025 | -1,420.14% |
| Dec 31, 2024 | -171.48% |
| Sep 30, 2024 | -124.60% |
| Jun 30, 2024 | -197.40% |
| Mar 31, 2024 | -204.89% |
| Dec 31, 2023 | -278.06% |
| Sep 30, 2023 | -1,242.22% |
| Dec 31, 2022 | -400.28% |
| Sep 30, 2022 | -582.90% |
| Jun 30, 2022 | -666.47% |
| Mar 31, 2022 | -1,015.71% |
| Dec 31, 2020 | -25,616.37% |
| Sep 30, 2020 | -3,785.32% |
| Jun 30, 2020 | -1,361.99% |
| Dec 31, 2019 | -2,515.10% |
| Jun 30, 2019 | -73,697.48% |
| Dec 31, 2018 | -71,930.07% |
API Access
Marker Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();